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Members of the Hedgehog (Hh) family of secreted proteins
function as morphogens to pattern developing tissues and
control cell proliferation. The seven-transmembrane domain
(7TM) protein Smoothened (Smo) is essential for the activa-
tion of all levels of Hh signaling. However, the mechanisms
by which Smo differentially activates low- or high-level Hh
signaling are not known [1]. Here we show that a newly iden-
tifiedmutation in the extracellular domain (ECD) of zebrafish
Smo attenuates Smo signaling. The Smo agonist purmorph-
amine [2] induces the stabilization, ciliary translocation, and
high-level signaling of wild-type Smo. In contrast, pur-
morphamine induces the stabilization but not the ciliary
translocation or high-level signaling of the Smo ECDmutant
protein. Surprisingly, a truncated form of Smo that lacks the
cysteine-rich domain of the ECD localizes to the cilium but is
unable to activate high-level Hh signaling. We also present
evidence that cilia may be required for Hh signaling in early
zebrafish embryos. These data indicate that the ECD, previ-
ously thought to be dispensable for vertebrate Smo func-
tion, both regulates Smo ciliary localization and is essential
for high-level Hh signaling.
Results and Discussion
The activation of Smoothened (Smo) is correlated with its
stabilization, conformational change, and membrane localiza-
tion, although the extent to which these aspects of Smo activa-
tion are interrelated is not known [3–11]. In Drosophila, Smo
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USAaccumulates at the plasma membrane upon activation of
Hedgehog (Hh) signaling [7], and targeting of Smo to the
plasma membrane causes constitutive activation [9, 10]. In
mammals, cilia are required for Hh signaling [12]. Smo local-
izes to the primary cilium in response to Hh signaling, and
this localization is required for Smo function [11]. However,
the ciliary localization of Smo is not sufficient for activation,
because Smo can accumulate at the cilium in the presence
of its inhibitor cyclopamine [13, 14]. The activation of Smo
may thus require distinct steps [13], although the mechanisms
that control this process remain unknown.
In a screen for zebrafish mutations affecting early embryonic
patterning, we identified s294. At 24 hr postfertilization (hpf),
s294 mutants (Figure 1B) show phenotypes similar to those
seen in the hi1640 allele of smo (Figure 1C), a presumed null
[15]. Mapping data showed that s294 maps close to smo,
and complementation tests showed that s294 fails to comple-
ment hi1640 (data not shown).
In zebrafish, Hh signaling is required for specification of
multiple cell types within the somites [16]. Superficial slow
fibers (SSFs), expressing slow myosin heavy chain (sMHC)
and Prox1, depend on medium- to low-level Hh signaling,
whereas muscle pioneer cells (MPs) require maximum levels
of Hh signaling and express high levels of Engrailed (Eng)
[16]. In smos294 mutants, MPs were absent and the SSF popu-
lation was reduced (Figures 1D–1I), indicating that high-level
Hh signaling was abolished and medium- to low-level signaling
diminished. Thus, s294 is a hypomorphic allele of smo.
To identify the molecular lesion in smos294, we sequenced its
open reading frame and found a G-to-A transition at position
374, leading to a cysteine-to-tyrosine substitution at residue
125 in the extracellular domain (ECD) of the protein
(Figure 1J). The C125 residue is one of ten highly conserved
ECD cysteines in the Smo/Frizzled (Fz) family of seven-trans-
membrane domain (7TM) proteins and is likely to participate
in a disulfide bridge that regulates tertiary structure [17]. The
C125Y substitution in Smos294 is thus likely to alter protein
conformation through disruption of a disulfide bond.
To test whether the SmoC125Y substitution alters protein
stability, we generated a version of mouse Smo in which the
analogous cysteine was replaced by tyrosine (SmoC151Y).
When expressed in zebrafish embryos or Smo2/2 mouse
embryonic fibroblasts (MEFs), SmoC151Y levels were reduced
compared to those of wild-type (WT) Smo (see Figure S1 avail-
able online). Treatment with the Smo agonist purmorphamine
increased levels of both WT and mutant Smo to equal to or
greater than that of untreated WT Smo (Figure S1). However,
stabilization of SmoC151Y was not sufficient to restore func-
tion: whereas WT Smo was able to restore Sonic hedgehog
(Shh) and purmorphamine responsiveness to Smo2/2 MEFs,
SmoC151Y failed to restore full pathway activity (Figure S1).
These results suggest that the ECD is an important determinant
of Smo stability and that it is required for full pathway activation.
Previous studies using truncated versions of Smo proposed
that the ECD was dispensable for vertebrate Smo activity [18,
19]. However, in Drosophila, three hypomorphic alleles of smo
have cysteine substitutions in the ECD similar to that in
smos294 (Figure 1J) [9, 20, 21], and a truncated version of
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smo mutants [9]. To further assess the signaling capabilities of
Smos294, we treated zebrafish smo mutants with purmorph-
amine from 8 until 24 hpf. As expected, purmorphamine treat-
ment had no effect on smohi1640 mutants at any concentration
tested (data not shown). In contrast, treatment of smos294
mutants with 20 or 25 mM purmorphamine resulted in a signifi-
cant degree of rescue of the morphological phenotype
(Figures 2A–2D). Treatment with 25 mM purmorphamine
induced complete rescue of SSFs in at least one somite in
43% (10 of 23) of smos294 mutant embryos (21.6 6 0.5 SSFs,
mean 6 SEM, n = 13 somites in three independent experi-
ments), suggesting that medium- to low-level Hh signaling
was restored (Figures 2E–2H; Table S1). This treatment also
induced a small but significant increase in SSFs in WT
embryos (Table S1; p < 0.02 by Student’s t test). These results
indicate that the Smos294 protein retains the ability to signal.
Although treatment with 20 mM purmorphamine significantly
increased the number of MPs in WT embryos (p < 0.0001 by
Student’s t test; Figures 2I and 2J; Table S1), it did not restore
MP formation in smos294 mutants (Figures 2K and 2L). Higher
concentrations of purmorphamine also had no effect (Table
S1). Thus, purmorphamine induced high-level Hh responses
in WT embryos but only medium- to low-level signaling in
smos294 mutants.
To further test the requirement of the ECD in Smo signaling,
we generated Myc-tagged SmoDCRD, a form of mouse Smo
that lacks the cysteine-rich domain (amino acids 68–182)
[18]. Injection of 250 pg Smo mRNA fully rescued zebrafish
smo mutants [11], and injection of 250 pg SmoDCRD mRNA
similarly rescued SSF development (Figures 2M–2P; Table S2).
Figure 1. s294 Is a Hypomorphic Allele of smo
with a C125Y Substitution in the Extracellular
Domain
(A–C) Comparison of wild-type (WT) (A), smos294
mutant (B), and smohi1640 mutant (C) embryos at
24 hr postfertilization (hpf) shows that s294
mutants have phenotypes similar to, although
weaker than, the smo null allele hi1640.
(D–F) Immunostaining for Prox1 (green) and slow
myosin heavy chain (sMHC) (red) assesses
medium- to low-level Hedgehog (Hh) signaling
in WT (D), smos294 mutant (E), and smohi1640
mutant (F) embryos at 24 hpf.
(G–I) Immunostaining for Engrailed (red)
assesses high-level Hh signaling in WT (G),
smos294 mutant (H), and smohi1640 mutant (I)
embryos at 24 hpf.
(J) Graphic representation of Smoothened (Smo).
Each amino acid is represented by a circle;
conserved cysteine residues in the extracellular
domain (ECD) are shown in green. The s294
mutation is shown in red; similar Drosophila
cysteine substitution alleles are shown in purple.
In contrast, SmoDCRD could not rescue
MPs in smohi1640 mutants, even at higher
doses of mRNA or in the presence of
purmorphamine (Figures 2Q–2T; Table
S2), and similarly failed to restore
Gli-luciferase activity in Smo2/2 MEFs
(Figure S2). SmoDCRD thus behaved
like stabilized Smos294 in being able to
activate medium- to low-level but not
high-level signaling. Together, these
results indicate that the ECD of vertebrate Smo, like that of
Drosophila Smo, is essential for full activity in vivo.
The failure of stabilization of SmoC151Y to restore high-level
signaling suggests that the SmoC151Y mutation interferes
with other regulatory processes that control Smo activity. To
test whether the C151Y mutation alters trafficking of Smo,
we examined the localization of WT Smo and SmoC151Y in
NIH 3T3 cells. As shown previously, Smo localizes to the cilium
in response to Hh signaling (Figure 3A; Figure S3) [11]. In
contrast, Hh could not induce any detectable ciliary localiza-
tion of SmoC151Y (Figure 3B), as is the case with ciliary local-
ization-deficient Smo (CLDSmo) [11] (Figure S3). Similar to Hh
exposure, treatment of NIH 3T3 cells with purmorphamine
caused the ciliary localization of WT Smo (Figure 3C) but did
not induce detectable ciliary localization of SmoC151Y or
CLDSmo (Figure 3D; Figure S3).
To investigate whether Smo localizes to cilia in zebrafish, we
injected mRNA encoding Myc-tagged Smo, SmoC151Y, and
SmoDCRD into zebrafish embryos at the one-cell stage and
looked at subcellular localization in cross-sections using anti-
bodies against the Myc tag and acetylated tubulin. To provide
spatial information, we used Tg(21.8gsc:GFP)ml1 embryos
[22], which express green fluorescent protein (GFP) in the cells
of the dorsal midline, a region of shh expression. At the end of
gastrulation (10 hpf), Smo was found localized to primary cilia
in 29%6 4% (mean6 SEM, n = 17 sections from a minimum of
four embryos) of ciliated cells surrounding the GFP-positive
dorsal midline (Figures 3E and 3J). In contrast, SmoC151Y
was not detected on cilia (0% 6 0%, mean 6 SEM, n = 14
sections from a minimum of six embryos; Figures 3F and 3J).
Treatment with 20 mM purmorphamine significantly increased
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(A–L) Purmorphamine treatment of WT and
smos294 mutant embryos. DMSO-treated WT (A,
E, and I), DMSO-treated smos294 mutant (C, G,
and K), purmorphamine-treated WT (B, F, and
J), and purmorphamine-treated smos294 mutant
(D, H, and L) embryos at 24 hpf are shown. Pur-
morphamine treatment did not significantly affect
morphology (B) and caused only a modest
increase in Prox1 (green) and sMHC staining
(red) (F) but strongly induced ectopic Engrailed
(Eng)-positive muscle pioneer cells (MPs) in WT
embryos (J). Purmorphamine treatment of
smos294 mutants resulted in significant rescue
of the morphological phenotype (D) and restored
Prox1 (green) and sMHC (red) expression (H), but
not Eng expression (L).
(M–T) Injection of SmoDCRD mRNA in WT and
smohi1640 mutant embryos. Prox1 (green) and
sMHC (red) staining (M–P) and Eng staining
(Q–T) are shown. Injection of 250 pg SmoDCRD
mRNA caused a complete rescue of Prox1 and
sMHC expression in smohi1640 mutants (P)
compared to uninjected mutants (O) and a slight
increase in Prox1 and sMHC expression in WT (N)
compared to control (M). In contrast, injection of
SmoDCRD mRNA had no effect on Eng expres-
sion in WT (R) compared to control (Q) and did
not rescue Eng expression in smohi1640 mutants
(T). For quantification, see Tables S1 and S2.the percentage of cells that showed ciliary localization of WT
Smo to 60% 6 5% (mean 6 SEM, n = 17 sections from
a minimum of five embryos, p < 0.0001 by Student’s t test;
Figures 3G and 3J) but did not induce detectable ciliary local-
ization of SmoC151Y (0% 6 0%, n = 14 sections from
a minimum of four embryos). SmoDCRD was clearly visible
on 17% 6 5% of the cilia (mean 6 SEM, n = 34 sections from
a minimum of five embryos; Figures 3I and 3J). The ciliary
localization of SmoDCRD was abolished by introducing the
CLD substitutions W549A and R550A [11]: neither CLDSmo
nor CLDSmoDCRD were observed on the cilium (Figure S4).
Comparison of different dorsoventral positions from the
midline (upper right of Figure 3J; Figure S5) showed a graded
distribution of ciliary Smo along the dorsoventral axis. In cells
flanking the dorsal midline, the ciliary localization of Smo was
significantly lower than that seen in the midline (14% 6 4%,
mean6SEM, n = 17 sections from a minimum of four embryos,
p < 0.02 by Student’s t test), and further ventrally, this
percentage dropped to 6% 6 3% (mean 6 SEM, n = 17
sections from a minimum of four embryos, p < 0.0002 by
Student’s t test). Purmorphamine induced uniformly high
levels of ciliary Smo, thereby abolishing the graded ciliary
localization (Figure 3J). Surprisingly, SmoDCRD localized to
cilia at medium-level percentages and showed no significant
difference between dorsal and more lateral positions
(Figure 3J), suggesting that the ciliary localization of
SmoDCRD is independent of Hh levels (Figure S6). Altogether,
these results suggest that Smo localizes to the cilium in cells
exposed to high levels of Hh and that the ECD of Smo is
involved in regulating its localization to the cilium.
These results also suggest that cilia may be required for Hh
signaling in zebrafish. A screen for mutations causing kidney
cysts identified zebrafish homologs of intraflagellar transport
genes, as well as other genes required for ciliary formationand function, including the novel gene qilin [23]. Unlike in the
mouse, none of the mutations in these genes causes overt
Hh phenotypes in zebrafish. However, it is unclear whether
any of these mutants display a complete and/or early loss of
cilia [23, 24], a condition that may be required to disrupt Hh
target gene expression. In support of a role for cilia in Hh
signaling in zebrafish, knockdown of ift80 has been reported
to cause a downregulation of embryonic ptc1 expression [25].
To begin to address the role of cilia in zebrafish Smo func-
tion, we used two nonoverlapping morpholinos (MOs) target-
ing the translation start site of qilin (qilin MO1 and MO2) and
analyzed the effects of qilin knockdown in early zebrafish
embryos. We further examined whether the results were
caused by a loss of cilia rather than a separate role of Qilin
by means of a dominant-negative Kif3b-GFP fusion protein
(dnKif3b) [26].
Embryos injected with dnKif3b mRNA, qilin MO1, or qilin
MO2 showed a similar range of morphological phenotypes
(Figure S7), suggestive of defects in convergence-extension
movements during gastrulation (Figure S8) and an upregula-
tion of canonical Wnt signaling (Figure S8), consistent with
previous reports [27, 28]. Furthermore, all injections caused
laterality defects (Figure S9). All injections also caused a signif-
icant reduction, and in some cases a complete loss, of
Kupffer’s vesicle (KV) cilia at 16 hpf (Figures 4A–4D;
Figure S10). The number of KV cilia was restored in qilin
MO2-injected embryos by coinjection of qilin mRNA
(Figure 4E; Figure S10). However, none of the qilin MO- or
dnKif3b mRNA-injected embryos displayed a complete loss
of cilia in the lumen of the neural tube or in the somites at 24
hpf, raising the possibility that embryos displaying complete
loss of cilia were lost to earlier lethality.
To analyze the level of Hh signaling in these injected
embryos, we examined the expression of the Hh target genes
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Expression of the ciliary marker acetylated tubulin (green) and either Myc-tagged WT Smo or Myc-tagged SmoC151Y (red) in NIH 3T3 cells (A–D) and zebra-
fish embryos at 10 hpf (E–J). Nuclei of NIH 3T3 cells were visualized with DAPI (blue).
(A and B) In NIH 3T3 cells, WT Smo localized to the cilium in response to Hh (A), whereas SmoC151Y did not (B).
(C and D) Treatment with the Smo agonist purmorphamine induced ciliary localization of WT Smo (C) but did not induce detectable ciliary localization of
SmoC151Y (D).
(E–I) Myc-tagged Smo mRNA was injected into Tg(21.8gsc:GFP)ml1 zebrafish embryos, which express GFP in the dorsal midline. WT Smo localized to the
cilia of cells surrounding the dorsal midline in embryos treated with DMSO (E), whereas SmoC151Y was not detected on the cilium (F). Purmorphamine treat-
ment increased the ciliary localization of Smo (G) but did not induce the ciliary localization of SmoC151Y (H). In contrast, SmoDCRD localized to the cilia in
untreated embryos (I). Scale bar in (E) represents 10 mm.
(J) The ciliary localization of Smo was quantified in locations away from the dorsal midline in sections (upper right), and the mean percentages of cilia
exhibiting colocalization with the Myc-tagged Smo constructs are shown. Error bars indicate SEM. Total numbers of sections counted are shown below.ptc1 and myod at the end of gastrulation (10 hpf). Injection of
dnKif3b mRNA, qilin MO1, or qilin MO2 caused a reduction
or loss of ptc1 expression (Figures 4F–4I; Figure S10), and
myod expression was reduced or absent in qilin MO2-injected
embryos (Figures 4K and 4L; Figure S10). Moreover, both ptc1
and myod expression were restored by coinjection of qilin
mRNA with qilin MO2 (Figures 4J and 4M; Figure S10), sug-
gesting that loss of cilia causes loss of Hh target gene expres-
sion in zebrafish. shh expression was not reduced in these
embryos (Figures 4N and 4O), indicating that the defect lies
in Hh signal transduction. Some loss of Hh target gene expres-
sion was also detected in the injected embryos at later stages
in the neural tube (Figure S11). Together, these results suggest
that cilia are required for high-level Hh signaling in zebrafish,
although the ultimate proof must await a genetic model.
Via a combination of genetic and pharmacological manipu-
lations of Smo, we have shown here that stabilization, ciliary
localization, and full activation of Smo are distinct andseparable aspects of its activity. Our results indicate that the
ECD of vertebrate Smo plays important roles in these distinct
Smo activities: it is essential for high-level but not low-level Hh
signaling, and it regulates both the stability and ciliary localiza-
tion of Smo. The inability of SmoC151Y to move to the cilium
suggests a role for the ECD in promoting ciliary localization
of Smo. However, the finding that deletion of the cysteine-
rich domain leads to moderate levels of ciliary localization in
a Hh-independent manner indicates that the ECD may also
function to prevent ciliary localization. The ECD of Smo may
thus both promote and restrict ciliary localization.
Furthermore, our data on SmoDCRD indicate that ciliary
localization is not sufficient for full activation of the Hh
signaling pathway, suggesting that other ECD-dependent
events are required for Smo activation of high-level signaling.
Conversely, the ability of purmorphamine to increase medium-
to low-level Hh signaling in smos294 mutants without causing
ciliary translocation of Smo suggests that medium- to
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cilium in zebrafish.
A recent study provided evidence that both Drosophila and
vertebrate Smo form constitutive dimers/oligomers through
the ECD [4]. One possible model is that dimerization of verte-
brate Smo through the ECD poises the ECD to mediate confor-
mational changes that regulate both ciliary translocation and
full activation of Smo. The smos294 mutation may prevent the
ECD-dependent conformational change that is required for
Smo trafficking to the cilium and high-level signaling.
SmoDCRD may similarly fail to adopt the conformational
changes required for full-level activation, but unlike
SmoC151Y, it escapes the regulatory mechanism that restricts
ciliary localization. It will be important to investigate whether
the ECD controls ciliary localization and high-level Hh
signaling by regulating Smo conformation.
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